GIM
VRTX icon

Generate Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Generate Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Sell
628
-25,706
-98% -$12M 0.01% 68
2025
Q4 		$11.9M Buy
26,334
+600
+2% +$259K 0.54% 46
2025
Q3 		$10.1M Buy
+25,734
New +$10.8M 0.51% 55
2024
Q2 		– Sell
-19,218
Closed -$8.03M – 92
2024
Q1 		$8.03M Buy
19,218
+7,394
+63% +$3.13M 0.58% 57
2023
Q4 		$4.81M Buy
+11,824
New +$4.37M 0.42% 70

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Generate Investment Management's VRTX Position: Q1 2026 in Review

Generate Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 98% in Q1 2026, selling an estimated $12M and leaving 628 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #68.

Generate Investment Management first reported a position in VRTX in Q4 2023 and has held it in 5 quarters since. The position peaked at $11.9M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Generate Investment Management held 628 shares of Vertex Pharmaceuticals worth $280K as of Q1 2026.
  • Generate Investment Management sold 25,706 Vertex Pharmaceuticals shares in Q1 2026, an estimated $12M.
  • Vertex Pharmaceuticals made up 0.01% of Generate Investment Management's portfolio in Q1 2026, its #68 holding.
  • Generate Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Generate Investment Management's Vertex Pharmaceuticals position peaked at $11.9M in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Generate Investment Management's 13F filing for Q1 2026, filed 16 Apr 2026.